vs
通用电气医疗(GEHC)与直觉外科(ISRG)财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是直觉外科的2.1倍($5.7B vs $2.8B),直觉外科净利率更高(29.8% vs 10.3%,领先19.5%),直觉外科同比增速更快(23.0% vs 7.1%),过去两年直觉外科的营收复合增速更高(17.4% vs 10.7%)
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业,旗下设四大业务板块:医学影像(含分子成像、CT、核磁共振、女性健康筛查、X射线系统)、超声、患者护理解决方案(聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护)及制药诊断业务。
直觉外科(Intuitive Surgical)是美国医疗科技企业,主打研发、生产及销售微创外科手术机器人产品,核心产品为达芬奇手术系统,可有效提升患者临床治疗效果。该公司为纳斯达克100、标普100及标普500指数成分股,截至2021年末全球达芬奇系统装机量达6730台,其中美国市场占4139台。
GEHC vs ISRG — 直观对比
营收规模更大
GEHC
是对方的2.1倍
$2.8B
营收增速更快
ISRG
高出15.9%
7.1%
净利率更高
ISRG
高出19.5%
10.3%
两年增速更快
ISRG
近两年复合增速
10.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $5.7B | $2.8B |
| 净利润 | $588.0M | $826.0M |
| 毛利率 | 39.7% | 66.1% |
| 营业利润率 | 14.5% | — |
| 净利率 | 10.3% | 29.8% |
| 营收同比 | 7.1% | 23.0% |
| 净利润同比 | -18.4% | 17.4% |
| 每股收益(稀释后) | $1.28 | $2.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GEHC
ISRG
| Q1 26 | — | $2.8B | ||
| Q4 25 | $5.7B | $2.9B | ||
| Q3 25 | $5.1B | $2.5B | ||
| Q2 25 | $5.0B | $2.4B | ||
| Q1 25 | $4.8B | $2.3B | ||
| Q4 24 | $5.3B | $2.4B | ||
| Q3 24 | $4.9B | $2.0B | ||
| Q2 24 | $4.8B | $2.0B |
净利润
GEHC
ISRG
| Q1 26 | — | $826.0M | ||
| Q4 25 | $588.0M | $794.8M | ||
| Q3 25 | $446.0M | $704.4M | ||
| Q2 25 | $486.0M | $658.4M | ||
| Q1 25 | $564.0M | $698.4M | ||
| Q4 24 | $721.0M | $685.7M | ||
| Q3 24 | $470.0M | $565.1M | ||
| Q2 24 | $428.0M | $526.9M |
毛利率
GEHC
ISRG
| Q1 26 | — | 66.1% | ||
| Q4 25 | 39.7% | 66.4% | ||
| Q3 25 | 38.7% | 66.4% | ||
| Q2 25 | 39.6% | 66.3% | ||
| Q1 25 | 42.1% | 64.7% | ||
| Q4 24 | 42.8% | 68.0% | ||
| Q3 24 | 41.7% | 67.4% | ||
| Q2 24 | 41.4% | 68.3% |
营业利润率
GEHC
ISRG
| Q1 26 | — | — | ||
| Q4 25 | 14.5% | 30.2% | ||
| Q3 25 | 12.7% | 30.3% | ||
| Q2 25 | 13.1% | 30.5% | ||
| Q1 25 | 13.2% | 25.7% | ||
| Q4 24 | 15.1% | 30.4% | ||
| Q3 24 | 13.9% | 28.3% | ||
| Q2 24 | 12.6% | 28.2% |
净利率
GEHC
ISRG
| Q1 26 | — | 29.8% | ||
| Q4 25 | 10.3% | 27.7% | ||
| Q3 25 | 8.7% | 28.1% | ||
| Q2 25 | 9.7% | 27.0% | ||
| Q1 25 | 11.8% | 31.0% | ||
| Q4 24 | 13.6% | 28.4% | ||
| Q3 24 | 9.7% | 27.7% | ||
| Q2 24 | 8.8% | 26.2% |
每股收益(稀释后)
GEHC
ISRG
| Q1 26 | — | $2.28 | ||
| Q4 25 | $1.28 | $2.19 | ||
| Q3 25 | $0.98 | $1.95 | ||
| Q2 25 | $1.06 | $1.81 | ||
| Q1 25 | $1.23 | $1.92 | ||
| Q4 24 | $1.58 | $1.89 | ||
| Q3 24 | $1.02 | $1.56 | ||
| Q2 24 | $0.93 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | — |
| 总债务越低越好 | $10.0B | — |
| 股东权益账面价值 | $10.4B | $17.6B |
| 总资产 | $36.9B | $20.1B |
| 负债/权益比越低杠杆越低 | 0.96× | — |
8季度趋势,按日历期对齐
现金及短期投资
GEHC
ISRG
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $5.9B | ||
| Q3 25 | $4.0B | $4.9B | ||
| Q2 25 | $3.7B | $5.3B | ||
| Q1 25 | $2.5B | $4.5B | ||
| Q4 24 | $2.9B | $4.0B | ||
| Q3 24 | $3.5B | $4.2B | ||
| Q2 24 | $2.0B | $4.8B |
总债务
GEHC
ISRG
| Q1 26 | — | — | ||
| Q4 25 | $10.0B | — | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | — | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — |
股东权益
GEHC
ISRG
| Q1 26 | — | $17.6B | ||
| Q4 25 | $10.4B | $17.8B | ||
| Q3 25 | $10.0B | $16.9B | ||
| Q2 25 | $9.7B | $17.8B | ||
| Q1 25 | $9.2B | $17.1B | ||
| Q4 24 | $8.4B | $16.4B | ||
| Q3 24 | $8.3B | $15.6B | ||
| Q2 24 | $7.8B | $14.7B |
总资产
GEHC
ISRG
| Q1 26 | — | $20.1B | ||
| Q4 25 | $36.9B | $20.5B | ||
| Q3 25 | $36.1B | $19.4B | ||
| Q2 25 | $35.5B | $20.2B | ||
| Q1 25 | $33.6B | $19.2B | ||
| Q4 24 | $33.1B | $18.7B | ||
| Q3 24 | $33.9B | $17.7B | ||
| Q2 24 | $31.9B | $16.6B |
负债/权益比
GEHC
ISRG
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
ISRG
| Instruments and accessories | $1.7B | 61% |
| Systems | $650.7M | 23% |
| Services | $433.7M | 16% |